Calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate is indicated for the treatment of cataplexy in people aged seven years of age and older with narcolepsy. In August 2021, the U.S. Food and Drug Administration (FDA) approved calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate for the treatment of idiopathic hypersomnia.
Xywav
Ganfyd
Kuru
Kuru 
Hwabyeong
Samu
Evenor
Uinyeo